Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
    • Podcast
  • Press Release
  • Media Coverage
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Inhibitor May Help Treat Acute Myeloid Leukemia
Disease Discoveries

Inhibitor May Help Treat Acute Myeloid Leukemia

By Roger AndersonOct 11, 2013
Share
Facebook Twitter Email
The National Cancer Institute estimates that 10,370 individuals will die this year of acute myeloid leukemia.

A group of inhibitors currently in clinical trials for the treatment of solid tumors may prove useful in targeting a treatment-resistant subset of acute myeloid leukemia (AML), a cancer that arises from the bone marrow.

Elizabeth Eklund, MD, professor in medicine-hematology/oncology, is working to determine if two proteins increase the production of a specific growth factor (Fgf2), which in turn promotes growth of leukemia cells.

If true, an Fgf2 receptor inhibitor might be used to augment chemotherapy or prevent relapse in individuals with AML. Eklund has been awarded a Leukemia and Lymphoma Society (LLS) Translational Research grant to pursue her hypothesis.

Professor Elizabeth Eklund, MD, received a grant to help turn her basic science discoveries into a potential drug, aiding patients fighting acute myeloid leukemia.

“The only way to move these projects out of the lab and into the clinic is through a funding mechanism like the one supplied by the LLS,” said Eklund, a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. “This grant will allow us to take our basic science research and start to apply it to potential drug treatments.”

During the next three years, Eklund will be working with animal models, and later human tissue samples, to determine if Fgf2 receptor inhibitors increase the effectiveness of chemotherapy or contribute to lower relapse rates. AML has several subtypes, and five-year survival rates range from 15-70 percent, with relapse rates between 33 and 78 percent.

“If we can show that either of these inhibitors are increasing the effectiveness of chemotherapy or preventing the leukemia from coming back, there will be an opportunity to apply for an additional two years of funding to bring our research to clinical trials,” Eklund said.

If that is achieved, she expects the project to evolve into a larger collaboration involving Frank Giles, MD, professor in medicine-hematology/oncology, and the Developmental Therapeutics Institute that he directs.

Cancer Research
Share. Facebook Twitter Email

Related Posts

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Comments are closed.

Latest News

Hospitals Bound to Patient Safety Rules that Aren’t all Backed by Evidence

Jun 24, 2022

Identifying Protein Interactions that Promote Cancer Growth

Jun 24, 2022

Combination Treatment May Improve Quality of Life in Kidney Cancer

Jun 23, 2022

Calcium Channel Blockers May Improve Chemotherapy Response

Jun 21, 2022

Expanded Role for Calcium Channels in T-Cells

Jun 17, 2022
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20220607_Feinberg Campus_0070
20220607_Feinberg Campus_0066
20220607_Feinberg Campus_0054
Northwestern University 2022. Photo by Jim Prisching
20220607_Feinberg Campus_0077
20220607_Feinberg Campus_0063
20220607_Feinberg Campus_0111
20220607_Feinberg Campus_0083
20220607_Feinberg Campus_0018
20220607_Feinberg Campus_0023
20220607_Feinberg Campus_0072 (2)
20220607_Feinberg Campus_0120

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2022 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.